Complete Filing Data
CG Oncology, Inc. reported Stockholders Equity of $752.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean CG Oncology, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income * | -$161.0M | -$88.0M | -$48.6M |
| Revenue From Contract With Customer Including Assessed Tax | $4.0M | $1.1M | $204.0K |
| Research And Development Expense | $116.6M | $82.1M | $45.8M |
| Other Nonoperating Income Expense | -$152.0K | $3.0K | -$62.0K |
| Operating Income Loss | -$190.8M | -$114.7M | -$55.4M |
| Nonoperating Income Expense | $29.8M | $26.6M | $6.8M |
| General And Administrative Expense | $73.5M | $33.7M | $9.9M |
| Operating Expenses | $115.8M | $55.7M | |
| Net Income Loss Available To Common Stockholders Basic | -$161.0M | -$88.0M | -$67.8M |
| Cost Of Sales | $4.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$43.8M | -$41.4M | -$34.5M | -$20.4M | -$18.9M | -$16.9M | -$11.8M | -$11.6M | -$8.7M |
| Revenue From Contract With Customer Including Assessed Tax | $1.7M | $0.00 | $52.0K | $43.0K | $111.0K | $529.0K | $9.0K | $0.00 | $194.0K |
| Research And Development Expense | $27.9M | $31.3M | $27.5M | $19.6M | $18.5M | $17.2M | $11.7M | $9.8M | $7.8M |
| Other Nonoperating Income Expense | -$100.0K | -$4.0K | $5.0K | -$2.0K | $8.0K | -$9.0K | -$8.0K | -$58.0K | $8.0K |
| Operating Income Loss | -$51.1M | -$48.7M | -$42.2M | -$28.3M | -$25.9M | -$22.5M | -$14.0M | -$12.3M | -$9.7M |
| Nonoperating Income Expense | $7.3M | $7.3M | $7.8M | $7.9M | $7.0M | $5.5M | $2.3M | $713.0K | $1.1M |
| General And Administrative Expense | $23.3M | $17.4M | $14.8M | $8.7M | $7.5M | $5.8M | $2.3M | $2.5M | $2.1M |
| Operating Expenses | $48.7M | $42.3M | $28.3M | $26.0M | $23.0M | $14.1M | $12.3M | $9.9M | |
| Net Income Loss Available To Common Stockholders Basic | -$20.4M | -$18.9M | -$16.9M | -$17.5M | -$15.4M | -$12.4M | |||
| Cost Of Sales | $1.6M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $752.6M | $733.4M | -$123.1M | -$77.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $32.5M | $257.1M | $8.3M | $88.1M |
| Non Cash Lease Expense | $34.0K | -$22.0K | $12.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$224.6M | $248.8M | -$79.9M | |
| Retained Earnings Accumulated Deficit | -$379.0M | -$218.0M | -$129.9M | |
| Property Plant And Equipment Net | $15.6M | $272.0K | $69.0K | |
| Prepaid Expense And Other Assets Current | $15.1M | $12.2M | $6.4M | |
| Other Assets Noncurrent | $1.7M | $94.0K | $19.0K | |
| Operating Lease Right Of Use Asset | $4.0M | $221.0K | $422.0K | |
| Operating Lease Liability Noncurrent | $3.1M | $52.0K | $244.0K | |
| Operating Lease Liability Current | $915.0K | $186.0K | $217.0K | |
| Marketable Securities Current | $709.7M | $484.9M | $179.4M | |
| Liabilities Current | $30.8M | $21.4M | $14.3M | |
| Liabilities And Stockholders Equity | $791.6M | $754.8M | $199.3M | |
| Liabilities | $39.0M | $21.4M | $14.5M | |
| Cash And Cash Equivalents At Carrying Value | $32.5M | $257.1M | $8.3M | |
| Assets Current | $759.5M | $754.2M | $194.1M | |
| Assets | $791.6M | $754.8M | $199.3M | |
| Accrued Liabilities And Other Liabilities | $24.2M | $14.7M | $10.4M | |
| Accounts Payable Current | $5.7M | $6.5M | $3.2M | |
| Redeemable Preferred Stock Dividends | $0.00 | $0.00 | $18.8M | |
| Deferred Offering Cost | -$3.4M | -$3.4M | ||
| Common Stock Value | $8.0K | $8.0K | ||
| Accounts And Other Receivables Net Current | $92.0K | |||
| Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | 38.4M | 38.4M | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $859.0K | $0.00 | $221.0K | |
| Reclassification Of Redeemable Convertible Preferred Stock To Common Stock | $307.9M | |||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $0.00 | $410.0K | |
| Goodwill | $10.3M | $0.00 | ||
| Success Fee Liability Non Current | $0.00 | $13.0K | ||
| Success Fee Liability Current Portion | $0.00 | $352.0K | ||
| Deferred Costs | $0.00 | $4.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $687.6M | $670.4M | $704.8M | $536.8M | $552.4M | $568.9M | -$107.6M | -$97.4M | -$86.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $45.1M | $14.6M | $41.5M | $43.4M | $25.2M | $77.5M | $10.3M | $78.0M | $693.0K | |
| Non Cash Lease Expense | -$14.0K | -$3.0K | $341.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$215.6M | $69.2M | -$87.5M | |||||||
| Retained Earnings Accumulated Deficit | -$337.7M | -$293.9M | -$252.4M | -$186.2M | -$165.8M | -$146.9M | ||||
| Property Plant And Equipment Net | $15.3M | $253.0K | $264.0K | $63.0K | $84.0K | $77.0K | ||||
| Prepaid Expense And Other Assets Current | $13.5M | $11.4M | $12.4M | $11.2M | $10.8M | $11.9M | ||||
| Other Assets Noncurrent | $114.0K | $522.0K | $516.0K | $53.0K | $53.0K | $53.0K | ||||
| Operating Lease Right Of Use Asset | $4.2M | $965.0K | $1.0M | $275.0K | $329.0K | $368.0K | ||||
| Operating Lease Liability Noncurrent | $3.3M | $706.0K | $781.0K | $71.0K | $118.0K | $184.0K | ||||
| Operating Lease Liability Current | $912.0K | $288.0K | $255.0K | $225.0K | $237.0K | $220.0K | ||||
| Marketable Securities Current | $635.1M | $646.4M | $647.0M | $497.3M | $527.7M | $489.0M | ||||
| Liabilities Current | $30.5M | $30.4M | $22.6M | $15.6M | $11.9M | $10.0M | ||||
| Liabilities And Stockholders Equity | $729.9M | $701.4M | $728.2M | $552.5M | $564.3M | $579.1M | ||||
| Liabilities | $42.3M | $31.1M | $23.4M | $15.7M | $12.0M | $10.2M | ||||
| Cash And Cash Equivalents At Carrying Value | $45.1M | $14.6M | $41.5M | $43.4M | $25.2M | $77.5M | ||||
| Assets Current | $695.8M | $673.0M | $701.2M | $552.1M | $563.9M | $578.6M | ||||
| Assets | $729.9M | $701.4M | $728.2M | $552.5M | $564.3M | $579.1M | ||||
| Accrued Liabilities And Other Liabilities | $20.4M | $23.0M | $15.7M | $11.3M | $7.1M | $5.1M | ||||
| Accounts Payable Current | $9.2M | $7.1M | $6.7M | $4.1M | $4.5M | $4.7M | ||||
| Redeemable Preferred Stock Dividends | $0.00 | $0.00 | $5.3M | $3.8M | $3.7M | |||||
| Deferred Offering Cost | -$232.0K | -$3.4M | ||||||||
| Common Stock Value | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | ||||
| Accounts And Other Receivables Net Current | $562.0K | $345.0K | $781.0K | $137.0K | $182.0K | $153.0K | ||||
| Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | 38.4M | 38.4M | ||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $859.0K | |||||||||
| Reclassification Of Redeemable Convertible Preferred Stock To Common Stock | $307.9M | |||||||||
| Preferred Stock Dividends Income Statement Impact | $410.0K | |||||||||
| Goodwill | $12.8M | |||||||||
| Success Fee Liability Non Current | ||||||||||
| Success Fee Liability Current Portion | ||||||||||
| Deferred Costs |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $26.7M | $11.4M | $1.5M |
| Net Cash Provided By Used In Operating Activities | -$132.3M | -$78.7M | -$45.7M |
| Net Cash Provided By Used In Investing Activities | -$245.8M | -$300.8M | -$121.2M |
| Net Cash Provided By Used In Financing Activities | $153.6M | $628.3M | $87.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.9M | $5.8M | $2.7M |
| Increase Decrease In Accounts Payable | -$1.6M | $3.3M | $2.0M |
| Depreciation Depletion And Amortization | $1.4M | $32.0K | $17.0K |
| Proceeds From Stock Options Exercised | $6.5M | $2.6M | $2.1M |
| Increase Decrease In Other Operating Assets | $1.6M | $75.0K | -$13.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $8.7M | $5.5M | $4.1M |
| Payments To Acquire Property Plant And Equipment | $134.0K | $234.0K | |
| Payments Of Success Fee Or Long Term Debt | $365.0K | $16.3M | |
| Payments To Acquire Short Term Investments | $1.05B | $517.6M | |
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $745.4M | $396.4M | |
| Proceeds From Issuance Initial Public Offering | $406.4M | ||
| Increase Decrease In Accounts And Other Receivables | $689.0K | ||
| Proceeds From Sale Maturity And Collections Of Investments | $844.1M | $745.4M | $396.4M |
| Payments To Acquire Investments | $1.07B | $1.05B | $517.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Share Based Compensation | $5.2M | $1.5M | $179.0K |
| Net Cash Provided By Used In Operating Activities | -$29.3M | -$26.0M | -$8.0M |
| Net Cash Provided By Used In Investing Activities | -$186.8M | -$307.4M | -$78.7M |
| Net Cash Provided By Used In Financing Activities | $450.0K | $402.7M | -$765.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $982.0K | $5.7M | -$224.0K |
| Increase Decrease In Accounts Payable | $214.0K | $1.4M | -$9.0K |
| Depreciation Depletion And Amortization | $24.0K | $4.0K | $4.0K |
| Proceeds From Stock Options Exercised | $682.0K | $68.0K | |
| Increase Decrease In Other Operating Assets | $35.0K | $33.0K | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $836.0K | -$4.1M | |
| Payments To Acquire Property Plant And Equipment | $16.0K | $12.0K | |
| Payments Of Success Fee Or Long Term Debt | $365.0K | $833.0K | |
| Payments To Acquire Short Term Investments | $361.9M | $453.3M | $78.7M |
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $200.1M | $145.9M | |
| Proceeds From Issuance Initial Public Offering | $406.4M | ||
| Increase Decrease In Accounts And Other Receivables | -$436.0K | ||
| Proceeds From Sale Maturity And Collections Of Investments | |||
| Payments To Acquire Investments |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 77.3M | 62.5M | 4.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 77.3M | 62.5M | 4.3M |
| Earnings Per Share Diluted | $-2.08 | $-1.41 | $-15.65 |
| Earnings Per Share Basic | $-2.08 | $-1.41 | $-15.65 |
| Common Stock Shares Outstanding | 80.7M | 76.2M | 5.2M |
| Common Stock Shares Issued | 80.7M | 76.2M | 5.2M |
| Common Stock Shares Authorized | 700.0M | 700.0M | 493.5M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 76.7M | 76.2M | 76.2M | 67.1M | 66.6M | 47.1M | 4.4M | 3.9M | 3.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 76.7M | 76.2M | 76.2M | 67.1M | 66.6M | 47.1M | 4.4M | 3.9M | 3.9M |
| Earnings Per Share Diluted | $-0.57 | $-0.54 | $-0.45 | $-0.30 | $-0.28 | $-0.36 | $-4.00 | $-3.93 | $-3.22 |
| Earnings Per Share Basic | $-0.57 | $-0.54 | $-0.45 | $-0.30 | $-0.28 | $-0.36 | $-4.00 | $-3.93 | $-3.22 |
| Common Stock Shares Outstanding | 78.3M | 76.2M | 76.2M | 67.5M | 66.7M | 66.6M | |||
| Common Stock Shares Issued | 78.3M | 76.2M | 76.2M | 67.5M | 66.7M | 66.6M | |||
| Common Stock Shares Authorized | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $26.7M | $11.4M | $1.5M |
| Stock Issued During Period Value New Issues | $6.5M | $2.6M | $2.1M |
| Investment Income Interest | $29.9M | $26.6M | $6.9M |
| Investment Income Net Amortization Of Discount And Premium | $1.0M | $5.0M | $2.9M |
| Additional Paid In Capital | $1.13B | $951.4M | $6.8M |
| Stock Issued During Period Value Conversion Of Convertible Securities | $307.9M | ||
| Stock Issued During Period Shares Conversion Of Convertible Securities | 38.4M | 38.4M | |
| Operating Costs And Expenses | $194.8M | $115.8M | $55.7M |
| Interest Paid Net | $103.0K | $376.0K | |
| Success Fees Amortization | -$37.0K | ||
| Amortization Of Loan Fees | $3.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.3M | $7.0M | $5.2M | $2.6M | $2.2M | $1.5M | $394.0K | $177.0K | $179.0K |
| Stock Issued During Period Value New Issues | $5.1M | $19.0K | $682.0K | $2.2M | $77.0K | $399.6M | $1.6M | $165.0K | $68.0K |
| Investment Income Interest | $7.4M | $7.3M | $7.7M | $7.9M | $6.9M | $5.5M | $2.3M | $771.0K | $1.0M |
| Investment Income Net Amortization Of Discount And Premium | $279.0K | $2.2M | |||||||
| Additional Paid In Capital | $1.03B | $964.2M | $957.2M | $722.9M | $718.1M | $715.8M | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $307.9M | ||||||||
| Stock Issued During Period Shares Conversion Of Convertible Securities | 38.4M | 38.4M | |||||||
| Operating Costs And Expenses | $52.8M | $28.3M | |||||||
| Interest Paid Net | $271.0K | ||||||||
| Success Fees Amortization | $335.0K | ||||||||
| Amortization Of Loan Fees | $7.0K |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.